In the BioHarmony Drug Report Database
Ceftizoxime
Cefizox (ceftizoxime) is a small molecule pharmaceutical. Ceftizoxime was first approved as Cefizox on 1983-09-15. It is used to treat acinetobacter infections, bacterial infections, bacterial meningitis, bacterial pneumonia, and bacterial skin diseases amongst others in the USA.
Trade Name
|
Cefizox |
|---|---|
Common Name
|
ceftizoxime |
ChEMBL ID
|
CHEMBL528 |
Indication
|
acinetobacter infections, bacterial infections, bacterial meningitis, bacterial pneumonia, bacterial skin diseases, bacteroides infections, escherichia coli infections, gonorrhea, haemophilus infections, infectious bone diseases, klebsiella infections, pelvic inflammatory disease, proteus infections, pseudomonas infections, sepsis, serratia infections, soft tissue infections, staphylococcal infections, streptococcal infections, urinary tract infections |
Drug Class
|
Cephalosporins |
Image (chem structure or protein)